Cargando…

Risk of cardiovascular disease and loss in life expectancy in NAFLD

BACKGROUND AND AIMS: Conflicting evidence exists on cardiovascular disease (CVD) risk in patients with NAFLD, and data are lacking on whether NAFLD increases mortality after a CVD event. Moreover, life expectancy in NAFLD has not been studied. We therefore examined CVD risk and life expectancy in pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shang, Ying, Nasr, Patrik, Widman, Linnea, Hagström, Hannes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790251/ https://www.ncbi.nlm.nih.gov/pubmed/35403232 http://dx.doi.org/10.1002/hep.32519

Ejemplares similares

Risk of hepatic and extrahepatic cancer in NAFLD: A population‐based cohort study
por: Björkström, Karl, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease and Risk of Dementia: A Population-Based Cohort Study
por: Shang, Ying, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease does not increase dementia risk although histology data might improve risk prediction
por: Shang, Ying, et al.
Publicado: (2020)

Four‐fold increased mortality rate in patients with Wilson's disease: A population‐based cohort study of 151 patients
por: Åberg, Fredrik, et al.
Publicado: (2023)

Association between temperature, sunlight hours and alcohol consumption
por: Hagström, Hannes, et al.
Publicado: (2019)

Time trends in mortality and life expectancy in 22,658 patients hospitalized with alcohol-associated cirrhosis: A nationwide cohort study
por: Wester, Axel, et al.
Publicado: (2023)

The risk of hepatocellular carcinoma in cirrhosis differs by etiology, age and sex: A Swedish nationwide population‐based cohort study
por: Bengtsson, Bonnie, et al.
Publicado: (2022)

NAFLD and cardiovascular disease
por: Martins, Elisabete, et al.
Publicado: (2018)

Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long‐term follow‐up study
por: Hagström, Hannes, et al.
Publicado: (2017)

Natural History of NAFLD/NASH
por: Ekstedt, Mattias, et al.
Publicado: (2017)

Moderate alcohol consumption is associated with significant fibrosis progression in NAFLD
por: Blomdahl, Julia, et al.
Publicado: (2023)

The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases
por: Wójcik-Cichy, Kamila, et al.
Publicado: (2018)

Adverse muscle composition is a significant risk factor for all-cause mortality in NAFLD
por: Linge, Jennifer, et al.
Publicado: (2022)

Lifetime risk, life expectancy, loss-of-life expectancy, and lifetime healthcare expenditures for psoriasis in Taiwan: a nationwide cohort followed from 2000 to 2017
por: Chiu, Hsien-Yi, et al.
Publicado: (2023)

Hepatic patatin‐like phospholipase domain‐containing 3 levels are increased in I148M risk allele carriers and correlate with NAFLD in humans
por: Ericson, Elke, et al.
Publicado: (2022)

Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles
por: Martínez‐Arranz, Ibon, et al.
Publicado: (2022)

NAFLD and cardiovascular diseases: a clinical review
por: Kasper, Philipp, et al.
Publicado: (2020)

Incidence, prevalence and mortality of chronic liver diseases in Sweden between 2005 and 2019
por: Nasr, Patrik, et al.
Publicado: (2023)

Peripheral artery disease and all-cause and cardiovascular mortality in patients with NAFLD
por: Ciardullo, S., et al.
Publicado: (2022)

Risk of injuries before and after a diagnosis of cirrhosis: A population-based cohort study
por: Shang, Ying, et al.
Publicado: (2023)

Effect of common genetic variants on the risk of cirrhosis in non‐alcoholic fatty liver disease during 20 years of follow‐up
por: Holmer, Magnus, et al.
Publicado: (2022)

From NAFLD to Cardiovascular Disease. Is it (Still) the Metabolic Syndrome?
por: MUNTEANU, MIHAI ALEXANDRU, et al.
Publicado: (2014)

Dysregulated lipid metabolism links NAFLD to cardiovascular disease
por: Deprince, Audrey, et al.
Publicado: (2020)

NAFLD and Cardiovascular Diseases: Epidemiological, Mechanistic and Therapeutic Considerations
por: Niederseer, David, et al.
Publicado: (2021)

Risk of fractures and subsequent mortality in non‐alcoholic fatty liver disease: A nationwide population‐based cohort study
por: Wester, Axel, et al.
Publicado: (2022)

Lifetime risks, loss of life expectancy, and health care expenditures for 19 types of cancer in Taiwan
por: Wu, Tzu-Yi, et al.
Publicado: (2018)

Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet – a randomised controlled trial
por: Holmer, Magnus, et al.
Publicado: (2021)

Dietary Fructose Reduction Improves Markers of Cardiovascular Disease Risk in Hispanic-American Adolescents with NAFLD
por: Jin, Ran, et al.
Publicado: (2014)

US life expectancy stalls due to cardiovascular disease, not drug deaths
por: Mehta, Neil K., et al.
Publicado: (2020)

Risk Behaviors Associated with Alcohol Consumption Predict Future Severe Liver Disease
por: Hagström, Hannes, et al.
Publicado: (2019)

Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease
por: Jarmakiewicz-Czaja, Sara, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease (NAFLD) and the cardiovascular disease (CVD) risk categories in primary care: is there an association?
por: Miptah, Hayatul Najaa, et al.
Publicado: (2020)

Temporal trend in mortality of cardiovascular diseases and its contribution to life expectancy increase in China, 2013 to 2018
por: Xia, Xue, et al.
Publicado: (2022)

Association Between NLR and NAFLD in Adults Exposed to Famine in Early Life
por: Liu, Ying, et al.
Publicado: (2022)

Among Patients With NAFLD, Treatment of Dyslipidemia Does Not Reduce Cardiovascular Mortality
por: Shahab, Omer, et al.
Publicado: (2018)

Factors Associated With Subjective Life Expectancy: Comparison With Actuarial Life Expectancy
por: Bae, Jaekyoung, et al.
Publicado: (2017)

Precipitous changes in nomenclature and definitions—NAFLD becomes SLD: Implications for and expectations of AASLD journals
por: Malhi, Harmeet, et al.
Publicado: (2023)

Dietary Risks for Liver Mortality in NAFLD: Global Burden of Disease Data
por: Paik, James M., et al.
Publicado: (2021)

The association between NAFLD and risk of chronic kidney disease: a cross-sectional study
por: Cao, Ying, et al.
Publicado: (2021)

Estimated Life Expectancy Without Recurrent Cardiovascular Events in Patients With Vascular Disease: The SMART‐REACH Model
por: Kaasenbrood, Lotte, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kkhrnqqga0p3eee01v1qslc1cv